Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:54 pm Purchase | 2024-09-30 | 13G | OPTINOSE INC OPTN | Great Point Partners, LLC | 1,020,463 9.990% | 254,855 (+33.29%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | NEUROGENE INC NGNE | Great Point Partners, LLC | 1,004,291 7.730% | 10,062 (+1.01%) | Filing History |
| 2024-11-14 4:52 pm Sale | 2024-09-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 6,934,982 9.250% | -484,373 (-6.53%) | Filing History |
| 2024-11-14 4:47 pm Sale | 2024-09-30 | 13G | UROGEN PHARMA LTD URGN | Great Point Partners, LLC | 758,786 1.800% | -1,861,759 (-71.04%) | Filing History |
| 2024-11-14 4:46 pm Sale | 2024-09-30 | 13G | ELEVATION ONCOLOGY INC ELEV | Great Point Partners, LLC | 0 0.000% | -3,877,172 (Position Closed) | Filing History |
| 2024-11-14 4:45 pm Sale | 2024-09-30 | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Great Point Partners, LLC | 0 0.000% | -3,703,433 (Position Closed) | Filing History |
| 2024-08-15 4:03 pm Purchase | 2024-08-06 | 13G | ELEVATION ONCOLOGY INC ELEV | Great Point Partners, LLC | 3,877,172 6.560% | 3,877,172 (New Position) | Filing History |
| 2024-08-05 4:03 pm Purchase | 2024-07-26 | 13G | PROMIS NEUROSCIENCES INC PMN | Great Point Partners, LLC | 120,228 9.990% | 120,228 (New Position) | Filing History |
| 2024-07-18 4:10 pm Purchase | 2024-07-16 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Great Point Partners, LLC | 855,900 9.990% | 855,900 (New Position) | Filing History |
| 2024-06-05 10:45 am Purchase | 2024-05-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 7,419,355 9.890% | 7,419,355 (New Position) | Filing History |
| 2024-04-08 4:10 pm Purchase | 2024-04-01 | 13G | OUTLOOK THERAPEUTICS INC P OTLK | Great Point Partners, LLC | 2,231,324 9.990% | 2,231,324 (New Position) | Filing History |
| 2024-02-14 4:39 pm Unchanged | 2023-12-31 | 13G | ZURA BIO LTD ZURA | Great Point Partners, LLC | 3,295,000 7.560% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:39 pm Unchanged | 2023-12-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Great Point Partners, LLC | 2,792,927 9.990% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:38 pm Unchanged | 2023-12-31 | 13G | UROGEN PHARMA LTD URGN | Great Point Partners, LLC | 2,620,545 8.490% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:38 pm Purchase | 2023-12-31 | 13G | OPTINOSE INC OPTN | Great Point Partners, LLC | 765,608 9.990% | 11,293 (+1.50%) | Filing History |
| 2024-02-14 4:37 pm Purchase | 2023-12-31 | 13G | NEUROGENE INC NGNE | Great Point Partners, LLC | 994,229 7.750% | 25,000 (+2.58%) | Filing History |
| 2024-02-14 4:37 pm Sale | 2023-12-31 | 13G | HERON THERAPEUTICS INC HRTX | Great Point Partners, LLC | 0 0.000% | -6,360,161 (Position Closed) | Filing History |
| 2024-02-14 4:37 pm Sale | 2023-12-31 | 13G | PRECISION BIOSCIENCES INC DTIL | Great Point Partners, LLC | 0 0.000% | -269,993 (Position Closed) | Filing History |
| 2024-02-14 4:36 pm Sale | 2023-12-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Great Point Partners, LLC | 2,085 0.260% | -1,976 (-48.66%) | Filing History |
| 2024-02-14 4:36 pm Purchase | 2023-12-31 | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Great Point Partners, LLC | 3,703,433 6.370% | 65,715 (+1.81%) | Filing History |